Toll-Like Receptors and Immunity to F. tularensis

Toll 样受体和对土拉弗拉菌的免疫

基本信息

  • 批准号:
    6912411
  • 负责人:
  • 金额:
    $ 31.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT 3 DESCRIPTION (provided by applicant): Francisella tularensis is a gram-negative bacterium that is the causative agent of tularemia, a highly infectious disease that can be fatal in humans, particularly in the pneumonic form. F. tularensis is an ideal bioweapon because of its extremely low LD50 and ease of aerosol dissemination. The disease is treatable with antibiotics if diagnosed early, but there is no licensed vaccine currently available and, therefore the population is at considerable risk in case of mass exposure. Many studies have focused on immunity to an attenuated live vaccine strain (LVS) derived from F. tularensis subsp. holoarctica, but virtually nothing is known about the immune response during pneumonic tularemia caused by the highly virulent F. tularensis subsp. tularensis. Toll-like receptors (TLRs) are critical innate immunity response elements that serve as a first line of defense by recognizing conserved, repeated patterns in molecules expressed by many pathogens. TLRs signal cells of the innate response and shape subsequent adaptive immunity by inducing expression of chemokines, pro-inflammatory cytokines and co-stimulatory molecules and thus are important targets for new adjuvants and vaccines. Our preliminary studies demonstrate a defect in the ability of primary alveolar macrophages from MyD88 mice to secrete TNF-a upon infection with F. tularensis LVS and increased susceptibility of MyD88-/- and TLR2-/- mice to LVS infection. Recent published studies suggest that F. tularensis may evade host innate immune responses. The central hypothesis for the proposed work is that activation/inhibition of TLR signaling plays a critical role in determining the nature of the innate response in the lung to aerosol infection by virulent F. tularensis. The proposed studies will test this hypothesis in an aerosol infection model of pneumonic tularemia in the mouse. We will 1) determine the role of TLR signaling in the host response to pulmonary infection with F. tularensis subsp. tularensis (Schu4) using KO mice and SiRNA; 2) identify and characterize TLR-regulated immune effector mechanisms that are involved in the innate response to pulmonary tularemia; and 3) define TLR signal-modulating mechanisms by which F. tularensis evades the host innate immune response. We expect that these studies will provide significant advances in our understanding of the overall immunopathogenesis of virulent F. tularensis and will provide critical insight into the role of Toll-like receptors in the host innate response to pneumonic tularemia.
项目3说明(申请人提供):图拉氏方济氏菌为革兰氏阴性杆菌 是图拉热症的病原体的细菌,图拉热症是一种高度传染性的疾病,在 人类,特别是肺炎的形式。土拉藻是一种理想的生物武器,因为它具有 极低的LD50,易于气雾剂传播。如果及早诊断,这种疾病是可以用抗生素治疗的,但目前没有获得许可的疫苗,因此,如果大规模接触,人群面临相当大的风险。许多研究都集中在对图拉氏亚种减毒活疫苗株(LVS)的免疫上。但对由高毒力的图拉氏杆菌亚种引起的肺炎性图拉热症期间的免疫反应几乎一无所知。图拉尔人。Toll样受体是关键的先天免疫反应元件,通过识别许多病原体表达的分子中保守的、重复的模式,作为第一道防线。TLRs通过诱导趋化因子、促炎细胞因子和共刺激分子的表达,向细胞发出先天反应的信号,并形成随后的获得性免疫,因此是新型佐剂和疫苗的重要靶点。我们的初步研究表明,MyD88小鼠的原代肺泡巨噬细胞在感染图拉氏原虫LVS时分泌肿瘤坏死因子-α的能力存在缺陷,并且MyD88-/-和TLR2-/-小鼠对LVS感染的易感性增加。近期 已发表的研究表明,图拉氏丝虫可能逃避宿主的先天免疫反应。这项工作的中心假设是,TLR信号的激活/抑制在确定肺部对图拉氏福氏杆菌强毒力气溶胶感染的先天反应的性质中起着关键作用。拟议的研究将在小鼠肺炎图拉热症的气雾剂感染模型中检验这一假设。我们将1)确定TLR信号在宿主对图拉氏丝虫亚种肺部感染反应中的作用。图拉氏菌(Schu4)利用KO小鼠和siRNA进行免疫调节;2)识别和表征TLR调节的免疫效应机制,涉及肺图拉热症的先天反应;以及3)确定图拉氏菌逃避宿主先天免疫反应的TLR信号调节机制。我们期望,这些研究将为我们理解图拉氏杆菌强毒力的整体免疫发病机制提供重要的进展,并将为了解Toll样受体在宿主对肺炎图拉热症的先天反应中的作用提供重要的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL T BERTON其他文献

MICHAEL T BERTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL T BERTON', 18)}}的其他基金

FACSAria Fusion cell sorter for Flow Cytometry Shared Resource
用于流式细胞术共享资源的 FACSAria Fusion 细胞分选仪
  • 批准号:
    10431534
  • 财政年份:
    2022
  • 资助金额:
    $ 31.23万
  • 项目类别:
A novel role for the TLR signaling adaptor TRAM
TLR 信号适配器 TRAM 的新作用
  • 批准号:
    8304012
  • 财政年份:
    2012
  • 资助金额:
    $ 31.23万
  • 项目类别:
A novel role for the TLR signaling adaptor TRAM
TLR 信号适配器 TRAM 的新作用
  • 批准号:
    8535602
  • 财政年份:
    2012
  • 资助金额:
    $ 31.23万
  • 项目类别:
Cooperative Mechanisms in IL-4-Induced Gene Expression
IL-4 诱导基因表达的协同机制
  • 批准号:
    6821998
  • 财政年份:
    2002
  • 资助金额:
    $ 31.23万
  • 项目类别:
Cooperative Mechanisms in IL-4-Induced Gene Expression
IL-4 诱导基因表达的协同机制
  • 批准号:
    6685175
  • 财政年份:
    2002
  • 资助金额:
    $ 31.23万
  • 项目类别:
Cooperative Mechanisms in IL-4-Induced Gene Expression
IL-4 诱导基因表达的协同机制
  • 批准号:
    7006994
  • 财政年份:
    2002
  • 资助金额:
    $ 31.23万
  • 项目类别:
Cooperative Mechanisms in IL-4-Induced Gene Expression
IL-4 诱导基因表达的协同机制
  • 批准号:
    6576428
  • 财政年份:
    2002
  • 资助金额:
    $ 31.23万
  • 项目类别:
Fluorescence, Chemiluminescence and Phosphor Imager
荧光、化学发光和磷光成像仪
  • 批准号:
    6440395
  • 财政年份:
    2002
  • 资助金额:
    $ 31.23万
  • 项目类别:
Cooperative Mechanisms in IL-4-Induced Gene Expression
IL-4 诱导基因表达的协同机制
  • 批准号:
    7146699
  • 财政年份:
    2002
  • 资助金额:
    $ 31.23万
  • 项目类别:
Mays Cancer Center at UT Health SA
UT Health SA 梅斯癌症中心
  • 批准号:
    10237954
  • 财政年份:
    1997
  • 资助金额:
    $ 31.23万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 31.23万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 31.23万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 31.23万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了